Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Retractable Technologies Inc (RVP)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: RVP (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -27.42% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.56M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.38 | 52 Weeks Range 0.56 - 1.21 | Updated Date 06/29/2025 |
52 Weeks Range 0.56 - 1.21 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.76 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -67.61% | Operating Margin (TTM) -56.38% |
Management Effectiveness
Return on Assets (TTM) -8.76% | Return on Equity (TTM) -25.89% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -15763612 | Price to Sales(TTM) 0.55 |
Enterprise Value -15763612 | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 0.14 | Enterprise Value to EBITDA 0.5 | Shares Outstanding 29937200 | Shares Floating 12595461 |
Shares Outstanding 29937200 | Shares Floating 12595461 | ||
Percent Insiders 57.85 | Percent Institutions 7.71 |
Upturn AI SWOT
Retractable Technologies Inc
Company Overview
History and Background
Retractable Technologies, Inc. (RVP) was founded in 1994. The company develops, manufactures, and markets safety medical devices with retractable needles and syringes designed to prevent needlestick injuries and bloodborne pathogen exposure.
Core Business Areas
- Safety Medical Devices: Development, manufacturing, and marketing of retractable needle syringes and safety needles for healthcare providers.
Leadership and Structure
Thomas J. Shaw is the founder and chairman and CEO of Retractable Technologies Inc. The company has a board of directors and a management team responsible for operations, sales, and product development.
Top Products and Market Share
Key Offerings
- Competitors: BDX,SMIT
- VanishPoint Syringes: Retractable needle syringes designed to prevent needlestick injuries. Market share data is not readily available publicly. Competitors include Becton Dickinson (BDX) and Smiths Medical. Estimated revenue contribution is significant but not precisely disclosed.
- Competitors: BDX,SMIT
- EasyPoint Needles: Retractable safety needles used for injections and blood collection. Market share data is not readily available publicly. Competitors include Becton Dickinson (BDX) and Smiths Medical. Estimated revenue contribution is significant but not precisely disclosed.
Market Dynamics
Industry Overview
The medical device industry is competitive and highly regulated, with a focus on safety, innovation, and cost-effectiveness. Demand for safety medical devices is driven by regulatory requirements, healthcare worker safety concerns, and the need to reduce healthcare costs associated with needlestick injuries.
Positioning
Retractable Technologies is positioned as a provider of innovative safety medical devices. Its competitive advantage lies in its patented retractable needle technology.
Total Addressable Market (TAM)
The global safety syringes market is estimated to be in the billions of dollars. Retractable Technologies occupies a niche market position within this TAM due to its patented technology and focus on retractable needle solutions. Actual TAM size varies depending on the source.
Upturn SWOT Analysis
Strengths
- Patented Retractable Needle Technology
- Focus on Safety Medical Devices
- Established Brand Reputation
- FDA Approved Products
- High-Margin Products
Weaknesses
- Limited Product Portfolio
- Reliance on a Few Key Customers
- Vulnerability to Competition
- Relatively Small Market Cap
- Dependence on Patents
Opportunities
- Expanding into New Markets
- Developing New Products
- Partnering with Healthcare Providers
- Increasing Awareness of Safety Medical Devices
- Capitalizing on Regulatory Changes
Threats
- Competition from Larger Medical Device Companies
- Generic Products
- Changes in Healthcare Regulations
- Product Liability Lawsuits
- Economic Downturns
Competitors and Market Share
Key Competitors
- BDX
- ITW
Competitive Landscape
Retractable Technologies competes with larger, more established medical device companies. Its competitive advantage lies in its patented retractable needle technology, but it faces challenges in terms of market reach and resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been variable and dependent on market demand and sales execution.
Future Projections: Future growth projections depend on market conditions and the company's ability to innovate and expand its market share. Analyst estimates should be consulted for specific projections.
Recent Initiatives: Recent initiatives include expanding sales efforts, developing new products, and seeking partnerships with healthcare providers.
Summary
Retractable Technologies is a niche player in the safety medical device market with patented technology. The company's future depends on its ability to capitalize on increasing demand for safety devices and expand its market share. It is vulnerable to competition from larger players and regulatory changes. Recent positive developments include product innovation and sales expansions.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Financial News Outlets
- Market Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Retractable Technologies Inc
Exchange NYSE MKT | Headquaters Little Elm, TX, United States | ||
IPO Launch date 2001-05-04 | Founder, Chairman, President & CEO Mr. Thomas J. Shaw | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 221 | Website https://www.retractable.com |
Full time employees 221 | Website https://www.retractable.com | ||
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.